https://doi.org/10.1016/s0140-6736(23)01796-8
B
Boqing Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
916
Citations
12
h-index
13
i10-index
Boqing Wang is an academic researcher from Loughborough University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & RNA modifications and cancer & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 12, co-authored 36 publications.
Papers by this author
worksAtezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 415 citations
Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance
2021 · British Journal of Cancer · 41 citations
https://doi.org/10.1038/s41416-020-01240-6
Baduanjin Exercise for Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2017 · Evidence-based Complementary and Alternative Medicine · 38 citations
https://doi.org/10.1155/2017/8378219
GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma
2024 · Pharmacological Research · 15 citations
https://doi.org/10.1016/j.phrs.2024.107490
A network meta-analysis
2020 · Medicine · 4 citations
https://doi.org/10.1097/md.0000000000020500
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat